European Medical Solutions (EBR:ALEMS)
Belgium
· Delayed Price · Currency is EUR 4.940
-0.060 (-1.20%)
Apr 29, 2026, 10:10 AM CET
EBR:ALEMS Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 1.84 | 0.55 | -0.71 | -5.58 | -0.24 | Upgrade
|
| Depreciation & Amortization | 1.07 | 2.04 | 2.2 | 4.09 | 1.93 | Upgrade
|
| Other Amortization | 1.11 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0.04 | 0.12 | Upgrade
|
| Other Operating Activities | 0.75 | 0.46 | -0 | 2.98 | 0.08 | Upgrade
|
| Change in Accounts Receivable | -4.02 | -2.03 | -2.53 | 0.04 | -0.13 | Upgrade
|
| Change in Inventory | -1.34 | 1.34 | -1.31 | -1.49 | 0.16 | Upgrade
|
| Change in Accounts Payable | 2.62 | 0.99 | -0.37 | 1.76 | -0.25 | Upgrade
|
| Change in Other Net Operating Assets | 3.33 | -0.8 | 0.45 | 0.32 | -1.34 | Upgrade
|
| Operating Cash Flow | 5.38 | 2.56 | -2.27 | 2.09 | 0.35 | Upgrade
|
| Operating Cash Flow Growth | 110.37% | - | - | 501.44% | - | Upgrade
|
| Capital Expenditures | -2.88 | -3.57 | -2.57 | -2.21 | -1.92 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.06 | - | - | - | Upgrade
|
| Cash Acquisitions | - | -0.15 | - | - | - | Upgrade
|
| Divestitures | - | - | - | 1.22 | - | Upgrade
|
| Investment in Securities | - | - | - | - | 0.05 | Upgrade
|
| Other Investing Activities | - | 0.77 | 1.06 | - | 0.53 | Upgrade
|
| Investing Cash Flow | -2.88 | -2.89 | -1.51 | -0.99 | -1.34 | Upgrade
|
| Long-Term Debt Issued | 4.8 | 3.57 | 5.43 | 3 | 3.48 | Upgrade
|
| Total Debt Issued | 4.8 | 3.57 | 5.43 | 3 | 3.48 | Upgrade
|
| Long-Term Debt Repaid | -6.25 | -2.23 | -1.69 | -2.42 | -0.96 | Upgrade
|
| Net Debt Issued (Repaid) | -1.45 | 1.33 | 3.74 | 0.58 | 2.52 | Upgrade
|
| Common Dividends Paid | - | - | - | - | -0.52 | Upgrade
|
| Other Financing Activities | -0.74 | -0.62 | -0 | 0.12 | - | Upgrade
|
| Financing Cash Flow | -2.19 | 0.72 | 3.74 | 0.71 | 2 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | 0 | - | - | Upgrade
|
| Net Cash Flow | 0.31 | 0.38 | -0.04 | 1.81 | 1.01 | Upgrade
|
| Free Cash Flow | 2.49 | -1.02 | -4.84 | -0.12 | -1.57 | Upgrade
|
| Free Cash Flow Margin | 4.72% | -2.12% | -11.39% | -0.32% | -4.14% | Upgrade
|
| Free Cash Flow Per Share | 0.59 | -0.24 | -1.14 | -0.03 | -22.98 | Upgrade
|
| Cash Interest Paid | 0.74 | 0.69 | - | - | - | Upgrade
|
| Levered Free Cash Flow | 1.51 | -3.45 | -4.58 | 1.63 | -15.31 | Upgrade
|
| Unlevered Free Cash Flow | 1.97 | -3.02 | -4.31 | 1.78 | -15.18 | Upgrade
|
| Change in Working Capital | 0.6 | -0.49 | -3.76 | 0.64 | -1.55 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.